Velazquez; Francisco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Velazquez; Francisco.The latest application filed is for "substituted tetrahydroisoquinoline compounds useful as gpr120 agonists".

Company Profile

5.25.20

Velazquez; Francisco - Clinton NJ
Velazquez; Francisco - Miami FL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists Grant 11,161,819 - Adams , et al. November 2, 2	2021-11-02
Thiazolidinone and oxazolidinone compounds and formulations Grant 11,014,940 - Traverse , et al. May 25, 2	2021-05-25
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20200347020 - Adams; Gregory L. ; et al.	2020-11-05
Heated shaving brush assembly having a removable regulator assembly Grant 10,799,015 - Velazquez , et al. October 13, 2	2020-10-13
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20190161448 - Adams; Gregory L. ; et al.	2019-05-30
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections Grant 9,433,621 - Arasappan , et al. September 6, 2	2016-09-06
HCV NS3 protease inhibitors Grant 9,328,138 - Rudd , et al. May 3, 2	2016-05-03
HCV NS3 protease inhibitors Grant 8,987,195 - Bara , et al. March 24, 2	2015-03-24
Tricyclic indole derivatives and methods of use thereof Grant 8,901,139 - Venkatraman , et al. December 2, 2	2014-12-02
Hcv Ns3 Protease Inhibitors App 20140296136 - Rudd; Michael T. ; et al.	2014-10-02
Substituted Pyridine And Pyrimidine Derivatives And Their Use In Treating Viral Infections App 20140242027 - Arasappan; Ashok ; et al.	2014-08-28
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections Grant 8,697,694 - Arasappan , et al. April 15, 2	2014-04-15
Hcv Ns3 Protease Inhibitors App 20140057836 - BARA; Thomas ; et al.	2014-02-27
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2	2013-12-24
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,557,848 - Chen , et al. October 15, 2	2013-10-15
4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,546,420 - Anilkumar , et al. October 1, 2	2013-10-01
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2	2012-03-27
Substituted Pyridine And Pyrimidine Derivatives And Their Use In Treating Viral Infections App 20110318305 - Arasappan; Ashok ; et al.	2011-12-29
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 8,067,379 - Bennett , et al. November 29, 2	2011-11-29
Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease App 20110150835 - Venkatraman; Srikanth ; et al.	2011-06-23
Substituted Indole Derivatives And Methods Of Use Thereof App 20110104110 - Anikumar; Gopinadhan N. ; et al.	2011-05-05
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ; et al.	2011-02-10
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,816,326 - Velazquez , et al. October 19, 2	2010-10-19
4, 5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100196319 - Anilkumar; Gopinadhan N. ; et al.	2010-08-05
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100098661 - Chen; Kevin X. ; et al.	2010-04-22
P1-nonepimerizable Ketoamide Inhibitors Of Hcv Ns3 Protease App 20100074867 - Venkatraman; Srikanth ; et al.	2010-03-25
Macrocyclic inhibitors of hepatitis C virus NS3-serine protease Grant 7,592,419 - Venkatraman , et al. September 22, 2	2009-09-22
Inhibitors of hepatitis C virus NS3/NS4a serine protease Grant 7,485,625 - Velazquez , et al. February 3, 2	2009-02-03
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus Grant 7,449,447 - Chen , et al. November 11, 2	2008-11-11
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,342,041 - Njoroge , et al. March 11, 2	2008-03-11
Sulfur Compounds As Inhibitors Of Hepatitis C Virus Ns3 Serine Protease App 20070197448 - Velazquez; Francisco ; et al.	2007-08-23
Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease App 20070042968 - Bennett; Frank ; et al.	2007-02-22
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease App 20050197301 - Njoroge, F. George ; et al.	2005-09-08
Novel inhibitors of hepatitis C virus NS3/NS4a serine protease App 20050153900 - Velazquez, Francisco ; et al.	2005-07-14
Macrocyclic inhibitors of hepatitis C virus NS3-serine protease App 20050119168 - Venkatraman, Srikanth ; et al.	2005-06-02
Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus App 20050085425 - Chen, Kevin X. ; et al.	2005-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.